MedTrace Logo

APBI Versus EBRT Therapy After Breast Conserving Surgery for Low-risk Breast Cancer

NCT00402519 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1300

Last updated 2016-05-13

No results posted yet for this study

Summary

To assess the role of interstitial brachytherapy alone compared to whole breast irradiation in a defined low-risk group of invasive breast cancer or ductal carcinoma in situ concerning local failure (all ipsilateral local recurrences) to affirm the hypothesis that local control rates in each arm are equivalent.

Conditions

Interventions

RADIATION

Accelerated partial breast irradiation

APBI with PDR and HDR brachytherapy

RADIATION

External beam whole breast irradiation

Standard Whole breast irradiation

Sponsors & Collaborators

  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Principal Investigators

  • Vratislav Strnad, MD · University Hospital Erlangen, Germany

  • Csaba Polgár, MD · National Institute of Oncology Budapest, Hungary

  • Oliver J Ott, MD · University Hospital Erlangen, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-11-30
Primary Completion
2009-11-30
Completion
2019-11-30

Countries

  • Austria
  • Germany
  • Hungary
  • Poland
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00402519 on ClinicalTrials.gov